Colorectal Neoplasms: all 5,738 studies
Page 40 of 58. Open to participants first (1,483), then studies with results posted, then the rest; newest registration first within each.
- The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major SurgeryCompletedNCT03064308Not applicable
- Turmeric Supplementation on Polyp Number and Size in Patients With Familial Adenomatous Polyposis.Status unknownNCT03061591Phase 2
- Irinotecan Plus Raltitrexed as Second-line Treatment in Advanced Colorectal Cancer PatientsStatus unknownNCT03053167Phase 2
- Validation of a New Prognostic Score for Adult Patients With RAS Wild-type mCRC Treated With Vectibix® and FOLFIRI or FOLFOX in First Line (VALIDATE)CompletedNCT03043950
- Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal SurgeryStatus unknownNCT03042091Early Phase 1
- Impact of Proximal Colon Retroflexion in Colorectal Cancer Screening ProgrammeCompletedNCT03041532Not applicable
- The IMPETUS Cancer Trial. A Technology Delivered Physical Activity Intervention in CancerStatus unknownNCT03036436Not applicable
- A Study of SC-006 and in Combination With ABBV-181 in Subjects With Advanced Colorectal CancerTerminatedNCT03035279Phase 1
- A Study of OMP-305B83 in Subjects With Metastatic Colorectal CancerTerminatedNCT03035253Phase 1
- Community Based Screening for Colorectal Cancer in an Underserved High Risk Population in NigeriaCompletedNCT03032874
- A Study of Brontictuzumab With Chemotherapy for Subjects With Previously Treated Metastatic Colorectal CancerCompletedNCT03031691Phase 1
- Discovery and Validate of Multi-genetic Biomarkers for Capecitabine in Chinese Colorectal PatientsStatus unknownNCT03030508
- Survivorship Care Plans in a Community Oncology PracticeCompletedNCT03028584
- Conventional Endoscopic Mucosal Resection vs Underwater Resection for Colorectal Non-pedunculated Colorectal LesionsCompletedNCT03021135Not applicable
- Safety and Pharmacokinetics of Recombinant Anti-EGFr Antibody in Patients With Metastatic Colorectal CancerCompletedNCT03017807Phase 1
- A Longitudinal Study of Cancer-related Fatigue Among Colorectal Cancer Patients During Adjuvant ChemotherapyStatus unknownNCT03013972
- A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic SurgeryCompletedNCT03010813Not applicable
- Prospective Translational Study Investigating Molecular Predictors of Resistance and Response to Regorafenib MonotherapyCompletedNCT03010722
- High-activity Natural Killer Immunotherapy for Small Metastases of Colorectal CancerCompletedNCT03008499Phase 1/2
- Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the LiverCompletedNCT03005002Phase 1
- Role of CD133 & Microsatellite Status in Evaluation of Rectosigmoid Cancer Young Adults Received Neoadjuvant TreatmentStatus unknownNCT03002727
- Intravenous Iron for Correction of Anaemia After Colorectal SurgeryStatus unknownNCT02999217Phase 4
- Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT StudyActive, not recruitingNCT02997228Phase 3
- PROSPECT-C: A Study of Biomarkers of Response or Resistance to Anti-EGFR Therapies in Metastatic Colorectal CancerCompletedNCT02994888
- Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic TumoursCompletedNCT02992912Phase 2
- Exercise Effect on Chemotherapy-Induced Neuropathic PainActive, not recruitingNCT02991677Not applicable
- Antibody DS-8273a Administered in Combination With Nivolumab in Subjects With Advanced Colorectal CancerTerminatedNCT02991196Phase 1
- Perioperative Immunonutrition in Colorectal Cancer Patients Undergoing Abdominal SurgeryCompletedNCT02987296Not applicable
- Withdrawal Time and Use of Wide-angle Endoscope to Increase the Adenoma Detection Rate of Screening ColonoscopyCompletedNCT02985944
- Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal CancerActive, not recruitingNCT02983578Phase 2
- Study With Atezolizumab Plus Bevacizumab in Patients With Chemotherapy Resistant, MSI-like, Colorectal CancerTerminatedNCT02982694Phase 2
- Comparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorectal Cancer PatientsCompletedNCT02980510Phase 2
- Impact of HLA-E Overexpression by Tumor Cells on the Biology of TIL in Colorectal CancerCompletedNCT02980146
- Adjuvant Chemotherapy In Elderly With Colon Cancer Stage IIICompletedNCT02978612Phase 2
- Cetuximab Monotherapy Maintenance Treatment in mCRCStatus unknownNCT02978313Phase 2/3
- Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or PancreasCompletedNCT02973672Phase 1/2
- Transanal Tube Drainage in Endoscopic Submucosal Dissection of the Colorectal TumorStatus unknownNCT02973490Not applicable
- Phase II Trial to Assess FOLFIRI+Aflibercept Efficacy in Patients With Oxaliplatin-pretreated Metastatic Colorectal Cancer With or Without ACE PolymorphismsCompletedNCT02970916Phase 2
- Long Term Effect of Oxaliplatin Treatment in Cancer SurvivorsCompletedNCT02970526
- Psychological Evaluation According Colonic Colonization by Escherichia Coli of Patients After Colorectal SurgeryCompletedNCT02970513Not applicable
- Vitamin C Intravenously With Chemotherapy in Advanced Colorectal CancerCompletedNCT02969681Phase 3
- Cold Snare Polypectomy Versus Endoscopic Mucosal Resection for Colonic Sessile Serrated PolypsCompletedNCT02967107Not applicable
- Care Pathways for Colorectal Cancer SurgeryCompletedNCT02965794
- Survivor Choices for Eating and Drinking - Colorectal CancerCompletedNCT02965521Not applicable
- Sym004 in Metastatic Colorectal Cancer and ECD-EGFR PatientsWithdrawnNCT02965417Phase 2
- Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus no HIPEC in Locally Advanced Colorectal Cancer (APEC Study)Status unknownNCT02965248Phase 3
- MS Versus NICE for Colorectal LesionsCompletedNCT02963207Not applicable
- Study of ASN003 in Subjects With Advanced Solid TumorsTerminatedNCT02961283Phase 1
- Gut Microbiome in Fecal Samples From Patients With Metastatic Cancer Undergoing Chemotherapy or ImmunotherapyTerminatedNCT02960282
- Equivalence of Monitoring by a Nurse Practitioner for Patients With Digestive CancerCompletedNCT02956876Phase 3
- An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of RuxolitinibActive, not recruitingNCT02955940Phase 2
- Simultaneous Resection of Colorectal Cancer With Synchronous Liver MetastasesCompletedNCT02954913Not applicable
- A Safety Study of SGN-2FF for Patients With Advanced Solid TumorsTerminatedNCT02952989Phase 1
- Evaluation of CTCs Combined With Tumor Marker Detection of Efficacy of Chemotherapy in mCRCStatus unknownNCT02948985
- Study on Aspirin Versus Placebo in Resected Colon Cancer With PI3K Mutation Stage III or II High RiskActive, not recruitingNCT02945033Phase 3
- Clinical Evaluation of PET-CT for Staging of Colorectal Lung MetastasesCompletedNCT02942901
- Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRCStatus unknownNCT02942706Phase 2/3
- FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer PatientsStatus unknownNCT02935764Phase 3
- FIT Mailing Protocol-For Cancer Screening NavigationStatus unknownNCT02934958Not applicable
- Metastatic Colorectal Cancer (RAS-wildtype) After Response to First-line Treatment With FOLFIR Plus CetuximabCompletedNCT02934529Phase 3
- Continuous Monitoring on the General WardCompletedNCT02933307Not applicable
- Identification of High Risk People for Colorectal Cancer and Evaluation of a Specific Surveillance SystemCompletedNCT02931825Not applicable
- Diagnostic Potential of Hypermethylated DNA in Colorectal CancerStatus unknownNCT02928120
- Efficacy and Safety Evaluation of Traditional Chinese Medicine in the Treatment of Advanced Colorectal CancerStatus unknownNCT02923622
- Aprepitant Without Steroid in Preventing Chemotherapy-induced Nausea and Vomiting in Patients With Colorectal CancerCompletedNCT02909478Phase 3
- Stereotactic Body Radiotherapy for Oligometastases From Colorectal CancerStatus unknownNCT02909114Phase 2
- Circulating Tumor Material in Colorectal Cancer and MelanomaCompletedNCT02907086
- Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal CancerCompletedNCT02906059Phase 1
- Study of I Line FOLFOX + Panitumumab vs 5FU + Panitumumab in RAS and BRAF WT Metastatic Colorectal Cancer Elderly PatientsStatus unknownNCT02904031Phase 2
- Expression of DMBT1 in Colorectal Cancer PatientsCompletedNCT02901600
- A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)CompletedNCT02900664Phase 1
- Multistate Relative Survival ModelCompletedNCT02894801
- Metronomic Versus Conventional Chemotherapy in as Maintenance Treatment in mCRCStatus unknownNCT02893540Phase 2/3
- Performance and Evaluation for CT Colonography ScreeningCompletedNCT02892721Not applicable
- Underwater Resection of Non-pedunculated Colorectal LesionsCompletedNCT02889679Not applicable
- Effects of Functional Exercise on Fitness and QoL in Cancer SurvivorsTerminatedNCT02889276Not applicable
- Dendritic Killer Cell-based Immunotherapy for Solid TumorsStatus unknownNCT02882659Phase 1
- Enhancing Prevention Pathways Toward Tribal Colorectal HealthCompletedNCT02882620Not applicable
- Molecular Determinants of Response to Preoperative Therapy in Patients With Locally Advanced Colorectal CancerStatus unknownNCT02877056
- Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other TumorsCompletedNCT02876224Phase 1
- Effects of Video Information on Preoperative Anxiety in Patients With Colorectal CancerStatus unknownNCT02873455Not applicable
- Correlation Between Circulating Tumour Markers Early Variations and Clinical Response in First Line Treatment of Metastatic Colorectal CancerCompletedNCT02872779Not applicable
- Donafenib for Previously Treated Metastatic Colorectal CancerCompletedNCT02870582Phase 3
- SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal CancerStatus unknownNCT02870153Phase 2
- Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of Simmitecan Monotherapy and Combination in Patients With Advanced Solid TumorsStatus unknownNCT02870036Phase 1
- A Study of Circulating Immune Cell Activity Changes in Blood of Colorectal Cancer PatientsCompletedNCT02869269
- Resection Versus Microwave Ablation for Resectable Colorectal Cancer Liver MetastasesTerminatedNCT02866344Not applicable
- Living Donor Liver Transplantation for Unresectable Colorectal Cancer Liver MetastasesActive, not recruitingNCT02864485Not applicable
- Young-Onset Colorectal CancerActive, not recruitingNCT02863107
- Detection and Characterization of Sessile Serrated Lesions (SSL) of the Right ColonStatus unknownNCT02861885
- Collaborative Network to Take Responsibility for Oral Anticancer TherapyStatus unknownNCT02861209Not applicable
- Prognostic Factors Affecting Outcomes in Multivisceral en Bloc Resection for Colorectal CancerCompletedNCT02859155Not applicable
- Special Combination of BBI608 and PembrolizumabTerminatedNCT02851004Phase 1/2
- Predictive Response to Chemotherapy (FOLFOX or FOLFIRI) by ex Vivo Culture 3D Technique in Metastatic Colorectal CancerCompletedNCT02849106Not applicable
- Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal CancerCompletedNCT02848443Phase 1
- Study of Fecal Bacteria in Early Diagnosis of Colorectal CancerCompletedNCT02845973
- Regional Native American Community Networks Program (RNACNP)CompletedNCT02843217Not applicable
- Cohort Study to Assess Impact of Chemotherapy Plus Bevacizumab on Health Related Quality of Life in First Line Metastatic Colorectal CancerStatus unknownNCT02842294
- Use of ctDNA for Monitoring of Stage III Colorectal CancerActive, not recruitingNCT02842203
- CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid TumorStatus unknownNCT02839954Phase 1/2